Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CTSS | P25774 | 5/20 | 0.34 |
| ▸ | CTSL | P07711 | 3/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | PPM1B | O75688 | 1/20 | 0.34 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.34 |
| ▸ | ACE | P12821 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19975065 | 0.80 | MDM2 (0.38) | ANPEPMEN1KMT2AMDM2ACE | |
| SCHEMBL19975230 | 0.77 | MEN1 (0.40) | ANPEPMEN1KMT2A | |
| SCHEMBL19974948 | 0.69 | KMT2A (0.46) | ANPEPMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11940451 | 0.68 | CYP3A4 (0.63) | MEN1KMT2AACESMN1; SMN2 | |
| SCHEMBL13458988 | 0.67 | KCNA5 (0.43) | MEN1KMT2A | |
| SCHEMBL19974876 | 0.66 | MEN1 (0.47) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2046868 | 0.65 | MEN1 (0.49) | MEN1KMT2A | |
| SCHEMBL21563181 | 0.65 | EPOR (0.45) | MEN1KMT2A | |
| SCHEMBL21183546 | 0.65 | PTGES (0.46) | MEN1KMT2A | |
| SCHEMBL20630035 | 0.64 | NPC1 (0.42) | MEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018050631-A1 | ANTIVIRAL COMPOUNDS | HAPLOGEN GMBH (AT) | 2018-03-22 | — | — | WO | disclosed |